This client has developed a DNA testing technology that enables the fast-track detection of diseases. During the last 18 months our FD has helped them raise funds through an EIS equity round, and a convertible loan note from the Future Fund. The investment has allowed the company to continue its R&D program as well as the final development and commercial launch of its first product.
Industry: Artificial Intelligence
By every measure – the depth of research, technical expertise, adaptability – our FDs’ have led finance functions pre- and post-investment. From conducting robust due diligence and modelling a multi-year plan for prospective investors, to changing the share structure and navigating legal requirements, our client has been able to further invest in the development of the product and bolster business functions and infrastructure.
Appointed to support the client’s debut on the New York Stock Exchange. Over $10m was generated to develop clinical trials and techniques for detecting various forms of cancer. We provided leadership in the form of a CFO, supported the uplisting process and prepared annual and quarterly accounts in line with listing regulations.
Industry: Listed manufacturing business
Our FDs have led many investment rounds over the last three years and have drawn on an extensive portfolio of private investors and private equity. We have conducted investment appraisals for a range of companies, including those with stock exchange requirements, to support the large-scale funding of capital. Generated £22.5m of investment, which involved £7.5m in asset financing and £15m in a public initial placing.
Like what you've heard?
Get in touch to find out more about how we can help your business.